Implanted glucose monitoring device.
The first FDA-approved, implantable glucose monitoring device,
known as the MiniMed Continuous Glucose Sensor system, will soon see
regular use at the Diabetes Center at Mercy Medical Center (Baltimore).
When the system is in use, a small needle--connected to a tube and
inserted into the fatty tissue of the abdomen--measures the glucose
level in the tissue every 10 seconds and sends a quantitatively
proportionate electronic signal to a monitor to which it is connected.
The data is later transferred to a computer and a report is produced
showing the patient's glucose level over a given period of time.
Thus, clinicians can track glucose levels at 5-minute intervals.